Sergio Traversa is CEO at RELMADA THERAPEUTICS, INC. (RLMD). They have made 19 open-market trades across 2 companies since 2015, most recently 2026-09-10.
CIK 0001565832
11 open-market purchases totalling $3.8M since 2015, against 8 sales. Across 10 scored buys the stock is up 34.4% at ninety days, and 31.8 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RLMD | 1,500,000 | $4.7M |
| ATNM | 2,000 | $2K |
| Total | $4.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 55% | 64% | 60% |
| Avg Move | +46.9% | +17.4% | +34.4% |
| Alpha | +37.8% | +17.2% | +31.8% |
| Scored | 11 | 11 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLMD | BUY | 2026-09-09 | 2026-09-11 | $4.14 | $828K | -16.7% | -22.4% | — |
| RLMD | BUY | 2025-12-15 | 2025-12-16 | $4.12 | $113K | -2.4% | -16.7% | +35.3% |
| RLMD | BUY | 2025-11-05 | 2025-11-06 | $2.20 | $600K | +64.2% | +60.4% | +40.4% |
| RLMD | BUY | 2025-08-26 | 2025-08-28 | $0.67 | $265K | +94.0% | +126.5% | +404.8% |
| RLMD | BUY | 2025-05-16 | 2025-05-20 | $0.50 | $335K | +9.0% | +4.4% | +2.2% |
| RLMD | BUY | 2024-09-09 | 2024-09-11 | $2.82 | $790K | -0.6% | -6.0% | -86.7% |
| RLMD | BUY | 2024-01-29 | 2024-01-31 | $3.85 | $664K | +26.6% | +56.0% | -16.5% |
| RLMD | BUY | 2022-12-08 | 2022-12-12 | $2.10 | $116K | -12.5% | +1.7% | -22.5% |
| RLMD | SELL | 2022-06-30 | 2022-07-05 | $18.80 | $1.1M | +17.2% | +30.3% | +84.8% |
| RLMD | SELL | 2021-03-09 | 2021-03-11 | $35.40 | $644K | -3.2% | +0.5% | -13.8% |
| RLMD | SELL | 2021-02-24 | 2021-02-26 | $34.06 | $505K | +3.0% | -3.5% | +7.3% |
| RLMD | SELL | 2021-02-11 | 2021-02-16 | $35.43 | $102K | -12.1% | -6.4% | -7.9% |
| RLMD | SELL | 2021-02-08 | 2021-02-10 | $35.17 | $788K | +0.9% | +4.9% | -0.1% |
| RLMD | SELL | 2021-02-02 | 2021-02-04 | $35.08 | $226K | +6.2% | +0.3% | +9.6% |
| RLMD | SELL | 2021-01-27 | 2021-01-29 | $32.39 | $644K | +6.9% | +3.1% | +18.8% |
| RLMD | SELL | 2021-01-22 | 2021-01-26 | $35.43 | $206K | -0.5% | -0.5% | +9.8% |
| ATNM | BUY | 2016-04-14 | 2016-04-18 | $2.02 | $6K | -9.2% | -18.4% | -18.4% |
| RLMD | BUY | 2015-12-15 | 2015-12-17 | $3.05 | $58K | +181.7% | +2.9% | +2.9% |
| RLMD | BUY | 2015-12-14 | 2015-12-16 | $2.97 | $89 | +181.7% | +2.9% | +2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.